Hematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousHematopoietic Stem CellsGraft vs Host DiseaseTransplantation, AutologousStem Cell TransplantationTransplantation ConditioningBone MarrowBone Marrow CellsHematologic NeoplasmsTransplantation ChimeraWhole-Body IrradiationPeripheral Blood Stem Cell TransplantationStem CellsTissue DonorsGraft SurvivalLeukemiaBusulfanLiver TransplantationHistocompatibility TestingHistocompatibilityHematopoiesisTreatment OutcomeAnemia, AplasticRecurrenceCord Blood Stem Cell TransplantationCombined Modality TherapyRetrospective StudiesImmunosuppressive AgentsRemission InductionKidney TransplantationTransplantation, IsogeneicCyclophosphamideGraft vs Leukemia EffectHematopoietic Stem Cell MobilizationAntigens, CD34Leukemia, Myeloid, AcuteMice, Inbred C57BLHepatic Veno-Occlusive DiseaseMyeloablative AgonistsTime FactorsBone and BonesChimerismCell DifferentiationHLA AntigensHematologic DiseasesTransplantation ImmunologyMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaSevere Combined ImmunodeficiencySurvival AnalysisBone Marrow PurgingMultiple MyelomaGraft RejectionSurvival RateGraft vs Tumor EffectLymphocyte TransfusionColony-Forming Units AssayFlow CytometryT-LymphocytesCell TransplantationLymphocyte DepletionMesenchymal Stem Cell TransplantationDisease-Free SurvivalAcute DiseaseMelphalanImmunosuppressionCell LineageLymphoma, Non-HodgkinBone Marrow DiseasesLeukemia, MyeloidHeart TransplantationCytomegalovirus InfectionsGranulocyte Colony-Stimulating FactorRadiation ChimeraSiblingsAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesVidarabineCells, CulturedAntilymphocyte SerumUnrelated DonorsLung TransplantationOrgan TransplantationSalvage TherapyFetal BloodCell SeparationStem Cell NicheCyclosporineCytarabineOpportunistic InfectionsEmbryonic Stem CellsPrognosisAdult Stem CellsTransplantationLeukocyte TransfusionInfectionImmunocompromised Host